| Diagnostic utility of exome sequencing for kidney disease EE Groopman, M Marasa, S Cameron-Christie, S Petrovski, VS Aggarwal, ... New England Journal of Medicine 380 (2), 142-151, 2019 | 593 | 2019 |
| Kidney biopsy findings in patients with COVID-19 S Kudose, I Batal, D Santoriello, K Xu, J Barasch, Y Peleg, P Canetta, ... Journal of the American Society of Nephrology 31 (9), 1959-1968, 2020 | 421 | 2020 |
| Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility N Perico, F Casiraghi, M Introna, E Gotti, M Todeschini, RA Cavinato, ... Clinical Journal of the American Society of Nephrology 6 (2), 412-422, 2011 | 368 | 2011 |
| Rituximab in idiopathic membranous nephropathy P Ruggenenti, P Cravedi, A Chianca, A Perna, B Ruggiero, F Gaspari, ... Journal of the American Society of Nephrology 23 (8), 1416-1425, 2012 | 351 | 2012 |
| Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome P Ruggenenti, B Ruggiero, P Cravedi, M Vivarelli, L Massella, M Marasà, ... Journal of the American Society of Nephrology 25 (4), 850-863, 2014 | 232 | 2014 |
| The copy number variation landscape of congenital anomalies of the kidney and urinary tract M Verbitsky, R Westland, A Perez, K Kiryluk, Q Liu, P Krithivasan, ... Nature genetics 51 (1), 117-127, 2019 | 194 | 2019 |
| Whole-exome sequencing in adults with chronic kidney disease: a pilot study S Lata, M Marasa, Y Li, DA Fasel, E Groopman, V Jobanputra, H Rasouly, ... Annals of internal medicine 168 (2), 100-109, 2018 | 187 | 2018 |
| C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy AS Bomback, D Santoriello, RS Avasare, R Regunathan-Shenk, ... Kidney international 93 (4), 977-985, 2018 | 157 | 2018 |
| The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis J Xie, L Liu, N Mladkova, Y Li, H Ren, W Wang, Z Cui, L Lin, X Hu, X Yu, ... Nature communications 11 (1), 1600, 2020 | 129 | 2020 |
| Deep phenotyping on electronic health records facilitates genetic diagnosis by clinical exomes JH Son, G Xie, C Yuan, L Ena, Z Li, A Goldstein, L Huang, L Wang, ... The American Journal of Human Genetics 103 (1), 58-73, 2018 | 108 | 2018 |
| Efficacy and safety of rituximab second-line therapy for membranous nephropathy: a prospective, matched-cohort study P Cravedi, MC Sghirlanzoni, M Marasà, A Salerno, G Remuzzi, ... American journal of nephrology 33 (5), 461-468, 2011 | 102 | 2011 |
| Membranous nephropathy associated with IgG4-related disease P Cravedi, M Abbate, E Gagliardini, M Galbusera, S Buelli, E Sabadini, ... American Journal of Kidney Diseases 58 (2), 272-275, 2011 | 99 | 2011 |
| Harmonizing clinical sequencing and interpretation for the eMERGE III network H Zouk, E Venner, NJ Lennon, DM Muzny, D Abrams, S Adunyah, ... The American Journal of Human Genetics 105 (3), 588-605, 2019 | 93 | 2019 |
| Mycophenolate mofetil in combination with steroids for treatment of C3 glomerulopathy: a case series RS Avasare, PA Canetta, AS Bomback, M Marasa, Y Caliskan, Y Ozluk, ... Clinical Journal of the American Society of Nephrology 13 (3), 406-413, 2018 | 81 | 2018 |
| CureGN study rationale, design, and methods: establishing a large prospective observational study of glomerular disease LH Mariani, AS Bomback, PA Canetta, MF Flessner, M Helmuth, ... American journal of kidney diseases 73 (2), 218-229, 2019 | 76 | 2019 |
| Rituximab in Nephrotic Syndrome of Steroid-Dependent or Frequently Relapsing Minimal Change Disease Or Focal Segmental Glomerulosclerosis (NEMO) Study Group: Rituximab in … P Ruggenenti, B Ruggiero, P Cravedi, M Vivarelli, L Massella, M Marasà, ... J Am Soc Nephrol 25 (4), 850-63, 2014 | 62 | 2014 |
| Clinical characteristics and treatment patterns of children and adults with IgA nephropathy or IgA vasculitis: findings from the CureGN study DT Selewski, JM Ambruzs, GB Appel, AS Bomback, RB Matar, Y Cai, ... Kidney international reports 3 (6), 1373-1384, 2018 | 58 | 2018 |
| Returning results in the genomic era: initial experiences of the eMERGE Network GL Wiesner, A Kulchak Rahm, P Appelbaum, S Aufox, ST Bland, CL Blout, ... Journal of Personalized Medicine 10 (2), 30, 2020 | 50 | 2020 |
| Exome-based rare-variant analyses in CKD S Cameron-Christie, CJ Wolock, E Groopman, S Petrovski, ... Journal of the American Society of Nephrology 30 (6), 1109-1122, 2019 | 49 | 2019 |
| Health-related quality of life in glomerular disease PA Canetta, JP Troost, S Mahoney, AJ Kogon, N Carlozzi, SM Bartosh, ... Kidney international 95 (5), 1209-1224, 2019 | 49 | 2019 |
